Joel Greenblatt's position in Chemed is currently worth $20.8M. That's 0.06% of their equity portfolio (443rd largest holding). The first Chemed trade was made in Q1 2011. Since then Joel Greenblatt bought shares 32 more times and sold shares on twenty occasions. The investor's estimated purchase price is $23.2M, resulting in a loss of 10%.